ResearcherShanghai Jiao Tong UniversityActive in the last 2 years
Jiajia Tang
Matched on ORCID iD 0000-0001-6036-6133; OpenAlex author ID A5077832673. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2021: 1 paper · 2022: none · 2023: 3 papers · 2024: 1 paper · 2025: 1 paper
Papers 6
- Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. Co-author DOI 10.1016/j.xpro.2025.103635↗
- CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches. Co-author DOI 10.1016/j.xcrm.2024.101692↗
- Liquid biopsy in pancreatic cancer - Current perspective and future outlook. First author DOI 10.1016/j.bbcan.2023.188868↗
- Single-cell omics: a new perspective for early detection of pancreatic cancer? Co-author DOI 10.1016/j.ejca.2023.112940↗
- Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity. First author DOI 10.1186/s13046-023-02883-y↗
- PPAR-delta acts as a metabolic master checkpoint for metastasis in pancreatic cancer Co-author DOI 10.1101/2021.11.15.468579↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christopher Heeschen · 6 shared papers, 2021–2025 · strength 0.99
- Paper Liquid biopsy in pancreatic cancer - Current perspective and future outlook. DOI 10.1016/j.bbcan.2023.188868↗
- Paper Single-cell omics: a new perspective for early detection of pancreatic cancer? DOI 10.1016/j.ejca.2023.112940↗
- Paper Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. DOI 10.1016/j.xpro.2025.103635↗
- Berina Šabanović · 4 shared papers, 2023–2025 · strength 0.68
- Paper Single-cell omics: a new perspective for early detection of pancreatic cancer? DOI 10.1016/j.ejca.2023.112940↗
- Paper Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. DOI 10.1016/j.xpro.2025.103635↗
- Paper CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches. DOI 10.1016/j.xcrm.2024.101692↗
- Quan Zheng · 4 shared papers, 2021–2025 · strength 0.57
- Paper Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. DOI 10.1016/j.xpro.2025.103635↗
- Paper CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches. DOI 10.1016/j.xcrm.2024.101692↗
- Paper Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity. DOI 10.1186/s13046-023-02883-y↗
- Yaru Zhao · 3 shared papers, 2023–2025 · strength 0.55
- Paper Liquid biopsy in pancreatic cancer - Current perspective and future outlook. DOI 10.1016/j.bbcan.2023.188868↗
- Paper Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. DOI 10.1016/j.xpro.2025.103635↗
- Paper CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches. DOI 10.1016/j.xcrm.2024.101692↗
- Qi Wang · 3 shared papers, 2023–2025 · strength 0.54
- Paper Single-cell omics: a new perspective for early detection of pancreatic cancer? DOI 10.1016/j.ejca.2023.112940↗
- Paper Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. DOI 10.1016/j.xpro.2025.103635↗
- Paper CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches. DOI 10.1016/j.xcrm.2024.101692↗
- Ke Jiang · 2 shared papers, 2023–2024 · strength 0.37
- Elisabetta Fenocchio · 2 shared papers, 2024–2025 · strength 0.33
- Da Fu · 2 shared papers, 2024–2025 · strength 0.33
- Chenlei Wen · 2 shared papers, 2024–2025 · strength 0.33
- Baiyong Shen · 2 shared papers, 2024–2025 · strength 0.33
- Patricia Sancho Andrés · 2 shared papers, 2021–2023 · strength 0.24
- Bruno Sáinz · 2 shared papers, 2021–2023 · strength 0.24
- Diana Behrens · 1 shared paper, 2023 · strength 0.14
- Sonia Alcalá · 1 shared paper, 2023 · strength 0.14
- Manuel M. Hidalgo · 1 shared paper, 2023 · strength 0.14
- Aldo Scarpa Scarpa · 1 shared paper, 2023 · strength 0.14
- Petra Jagušt · 1 shared paper, 2021 · strength 0.10
- Sarah Courtois · 1 shared paper, 2021 · strength 0.10
- Sara Maria David Trabulo · 1 shared paper, 2021 · strength 0.10
- Beatriz Parejo-Alonso · 1 shared paper, 2021 · strength 0.10
- Pilar Espiau-Romera · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.